|
|
Karki, S.; Pforte, B.; Karky, B. S.; Statz, J.; Dangi, R. B.; Khanal, D. R.; Chand, N. B.; Poudel, M.; Maraseni, T.; Cadman, T.; Lopez, F.; Delma, S.; Wangchuk, S.; Norbu, L.; Oo, T. N.; Rawat, V. R. S.; Singh, T. P.; Sharma, J. V.; Windhorst, K.
REDD+ Initiative has prepared a UNFCCC submission report “The Development of REDD+ Safeguards in the Hindu Kush Himalaya: Recent Experiences and Processes” to demonstrate that the participating HKH countries are committed to developing REDD+ safeguards
. This document illustrates the ongoing progress made on integrating safeguard in REDD+ programme in the HKH countries that are in their REDD readiness phase. This report synthesizes the overall progress of National Safeguard System, by analyzing gaps and common challenges to implement REDD+ safeguards in Bhutan, India, Myanmar and Nepal and recommends the way forward. This report, prepared through series of regional level South-South learning workshops in 2015 and 2016, is a testament of how the HKH countries are trying to comply with the UNFCCC guidelines by engaging in the development of National Safeguard System
Read More
|
|
|
We performed a retrospective study to identify the risk factors for cytomegalovirus (CMV) disease among 570 renal transplant recipients
. By means of a multivariate analysis we identified antilymphocyte antibody therapy (odds ratio [OR]: 4.6; 95% confidence interval [CI]: 2.0 to 10.6), high doses of corticosteroids (OR: 3.4; 95% CI: 1.2 to 10.1), and double renal transplant (OR: 4.1; 95% CI: 1.5 to 11.5). To the best of our knowledge, this is the first study to suggest that in addition to other well-known risk factors for CMV disease (ie, therapy with anti-lymphocyte antibodies or high doses of corticosteroids), the use of double renal transplantation appears to increase the risk of CMV disease in this population. © 2005 by Elsevier Inc. All rights reserved
Read More
|
email alert
or subscribe to the 
RSS feed.
